Eun‐Young Kim

756 total citations
28 papers, 531 citations indexed

About

Eun‐Young Kim is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Eun‐Young Kim has authored 28 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Eun‐Young Kim's work include Drug Transport and Resistance Mechanisms (5 papers), Drug-Induced Adverse Reactions (4 papers) and Urticaria and Related Conditions (3 papers). Eun‐Young Kim is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Drug-Induced Adverse Reactions (4 papers) and Urticaria and Related Conditions (3 papers). Eun‐Young Kim collaborates with scholars based in South Korea, United States and Vietnam. Eun‐Young Kim's co-authors include Jae‐Gook Shin, Ji‐Hong Shon, Jungsug Gwak, Dong‐Eun Kim, Sangtaek Oh, Jong‐Lyul Ghim, Doo‐Yeoun Cho, Tae Kook Kim, Munju Cho and Mina Kim and has published in prestigious journals such as Journal of Cell Science, Clinica Chimica Acta and British Journal of Clinical Pharmacology.

In The Last Decade

Eun‐Young Kim

27 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eun‐Young Kim South Korea 10 135 93 60 55 50 28 531
Bipin Mistry United States 13 99 0.7× 68 0.7× 33 0.6× 36 0.7× 31 0.6× 24 469
He Sun China 13 93 0.7× 59 0.6× 65 1.1× 87 1.6× 34 0.7× 32 486
Tai Ning Lam Hong Kong 12 101 0.7× 43 0.5× 60 1.0× 46 0.8× 43 0.9× 29 476
Yun‐Kyoung Song South Korea 18 353 2.6× 81 0.9× 31 0.5× 68 1.2× 63 1.3× 62 1.0k
Keri Lestari Indonesia 13 180 1.3× 45 0.5× 47 0.8× 33 0.6× 40 0.8× 71 679
Névine Zariffa United States 14 47 0.3× 48 0.5× 52 0.9× 52 0.9× 60 1.2× 30 650
Małgorzata Kozłowska−Wojciechowska Poland 15 134 1.0× 58 0.6× 21 0.3× 36 0.7× 103 2.1× 55 624
Natalie Dayneka Canada 7 213 1.6× 89 1.0× 118 2.0× 99 1.8× 21 0.4× 15 741

Countries citing papers authored by Eun‐Young Kim

Since Specialization
Citations

This map shows the geographic impact of Eun‐Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun‐Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun‐Young Kim more than expected).

Fields of papers citing papers by Eun‐Young Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun‐Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun‐Young Kim. The network helps show where Eun‐Young Kim may publish in the future.

Co-authorship network of co-authors of Eun‐Young Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Eun‐Young Kim. A scholar is included among the top collaborators of Eun‐Young Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun‐Young Kim. Eun‐Young Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moon, Jung‐Joon, Ho-Sook Kim, Joo-Cheol Shim, et al.. (2023). Possible genetic biomarker associated with antipsychotic-induced amenorrhea in female patients with schizophrenia. International Clinical Psychopharmacology. 39(1). 29–35. 2 indexed citations
3.
Kim, Si Hyun, Eun‐Young Kim, Eun-Hee Park, et al.. (2022). Performance of MALDI-TOF Mass Spectrometry (VITEK MS) in the Identification of Salmonella Species. Microorganisms. 10(10). 1974–1974. 8 indexed citations
4.
Kim, Eun‐Young, Seok Jin Choi, Jong‐Lyul Ghim, et al.. (2021). Associations between HLA-A, -B, and -C alleles and iodinated contrast media–induced hypersensitivity in Koreans. Translational and Clinical Pharmacology. 29(2). 107–107. 3 indexed citations
5.
Phương, Nguyễn Thị Thu, Jin Ah Jung, Jong‐Lyul Ghim, et al.. (2021). Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. British Journal of Clinical Pharmacology. 88(3). 1159–1169. 4 indexed citations
6.
Kim, Eun‐Young. (2021). Biobanks as a Treasury for Precision Medicine. Healthcare Informatics Research. 27(2). 93–94. 1 indexed citations
7.
Kim, Eun‐Young, Mi‐Yeong Kim, Chan Sun Park, et al.. (2019). Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test. Translational and Clinical Pharmacology. 27(2). 64–64. 6 indexed citations
8.
Ghim, Jong‐Lyul, Nguyễn Thị Thu Phương, Min Jung Kim, et al.. (2019). <p>Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets</p>. Drug Design Development and Therapy. Volume 13. 1623–1632. 10 indexed citations
9.
10.
Oh, Minkyung, et al.. (2017). Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers. Drug Design Development and Therapy. Volume 11. 3543–3550. 7 indexed citations
11.
Kim, Eun‐Young. (2017). Development and Application of Direct Data Capture for Monitoring Medication Compliance in Clinical Trials. Healthcare Informatics Research. 23(4). 249–249. 5 indexed citations
12.
Kim, Eun‐Young, et al.. (2016). HLA-A*24:02/B*51:01haplotype and lamotrigine-induced cutaneous adverse drug reactions in Koreans. Translational and Clinical Pharmacology. 24(3). 143–143. 4 indexed citations
13.
Oh, Minkyung, et al.. (2015). The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes. British Journal of Clinical Pharmacology. 81(2). 301–312. 18 indexed citations
14.
Jiang, Fen, Chang‐Woo Yeo, Minkyung Oh, et al.. (2013). Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals. Pharmacogenetics and Genomics. 23(3). 175–179. 5 indexed citations
15.
Yeo, Chang‐Woo, Minkyung Oh, Jong‐Lyul Ghim, et al.. (2013). The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. British Journal of Clinical Pharmacology. 77(5). 821–830. 16 indexed citations
16.
Bae, Soo Kyung, Minjung Kim, Eon‐Jeong Shim, et al.. (2009). HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies. Biomedical Chromatography. 23(6). 568–572. 42 indexed citations
17.
Gwak, Jungsug, Soo Jin Jung, Eun‐Young Kim, et al.. (2009). Stimulation of protein kinase C‐α suppresses colon cancer cell proliferation by down‐regulation of β‐catenin. Journal of Cellular and Molecular Medicine. 13(8b). 2171–2180. 32 indexed citations
18.
Song, Im‐Sook, et al.. (2007). The effect of ABCG2 V12M, Q141K and Q126X, known functional variantsin vitro, on the disposition of lamivudine. British Journal of Clinical Pharmacology. 64(5). 645–654. 44 indexed citations
19.
Gwak, Jungsug, Munju Cho, Jaejoon Won, et al.. (2006). Protein-kinase-C-mediated β-catenin phosphorylation negatively regulates the Wnt/β-catenin pathway. Journal of Cell Science. 119(22). 4702–4709. 95 indexed citations
20.
Kim, Eun‐Young, et al.. (2005). Effect of Chungpaesagan-tang on Ischemic Damage Induced by Middle Cerebral Artery Occlusion in Diabetic rats. 26(2). 217–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bipin Mistry Breakdown of academic impact, for papers by He Sun Breakdown of academic impact, for papers by Tai Ning Lam Breakdown of academic impact, for papers by Yun‐Kyoung Song Breakdown of academic impact, for papers by Keri Lestari Breakdown of academic impact, for papers by Névine Zariffa Breakdown of academic impact, for papers by Małgorzata Kozłowska−Wojciechowska Breakdown of academic impact, for papers by Natalie Dayneka
Rankless by CCL
2026